Uzma Samadani, M.D. Ph.D is a private practice neurosurgeon who was named “Top Doctor in Neurosurgery” six times. Dr. Samadani is certified by the American Board of Neurological Surgeons and a fellow of the American College of Surgeons and American Association of Neurological Surgeons. She is also an Associate Professor in the Department of Bioinformatics and Computational Biology at the University of Minnesota, and staff neurosurgeon at the Minneapolis VAHCS. She founded the neurodiagnostic start-up Oculogica Inc, which has developed the first FDA approved concussion diagnostic device, and holds multiple patents related to brain injury treatment.
She is currently accepting new patients at US Neurosurgery Associates and works with many insurance plans, including Medicare and Medicaid. In addition, Dr. Samadani also provides second opinion services. Dr. Samadani will review your scans remotely and communicate with you via email or see you in person at her clinic to provide her expert second opinion on your condition.
Medical School: University of Illinois College of Medicine at Chicago. 1999
Residency: Hospital of the University of Pennsylvania. 2006
Certifications: American Board of Neurological Surgery
Hospital Affiliations: Maple Grove Hospital, Maple Grove, MN
North Memorial Health Hospital, Robbinsdale, MN
Dr. Samadani has been named one of the “Most Creative People in Business” by Fast Company magazine. She was named Minneapolis St-Paul Magazine's “Top Doctors in Neurosurgery” lists 2016 through 2019. Dr. Samadani was on the cover of the “Top Doctors” edition in 2018 with the byline “The Doctor Will Save You Now”. She also was awarded the “Courageous Women in Healthcare” award in 2018 by the Women’s Health Leadership Trust. Minnesota Monthly dubbed her a “Top Doctor in Minnesota” in 2018 and 2019.
She is on the Executive Committee of the American Association of Neurological Surgeons/Congress of Neurological Surgeons Section on Neurotrauma and Critical Care and served as Scientific Program Chair for their meeting in conjunction with the National Neurotrauma Society from 2014-2017. She also served as Board Chair of ThinkFirst Foundation from 2019 to 2021. She is past Chair of the Minnesota State Traumatic Brain and Spinal Cord Injury Research Program and a Past-President of Women in Neurosurgery. She serves on the council of the G4 Alliance.
She has received more than $6M in research grants from national and international funding agencies to study diagnostics, risks, outcomes and treatments for brain injury. These include the United States Veterans Administration, Department of Defense, National Space and Biomedical Research Institute, Abbott Diagnostic Laboratories, American College of Surgeons, American Association of Neurological Surgeons, Thrasher Research Fund, Integra, the Steven and Alexandra Cohen Foundation and several other organizations.
Her research on brain injury has been discussed in the New York Times, LeMonde, LeFigaro, Wired, Washington Post, Sports Illustrated, Forbes, and Minneapolis Star Tribune as well as numerous other media sources. She has been a speaker at TedMed, the North American Brain Injury Society, National Neurotrauma Society, American Association of Neurological Surgeons meeting and multiple other conferences. She has published more than 60 peer-reviewed scientific papers and an additional 30 reviews and chapters including in the Journal of Neurotrauma, JAMA Neurology, Journal of Neurosurgery and the New England Journal of Medicine. Dr. Samadani also served as an unaffiliated neurotrauma consultant to the National Football League from 2015 to 2018.